Raf-1 physically interacts with Rb and regulates its function: A link between mitogenic signaling and cell cycle regulation

Molecular and Cellular Biology

Volumn 18, Issue 12, 1998, Pages 7487-7498

  Wang, Sheng ^a   Ghosh, Richik N ^a,b   Chellappan, Srikumar P ^a  

^a Columbia University ^*  (United States)

^b Cellomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; RAF PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

MAMMALIA;

EID: 0031724929     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.12.7487     Document Type: Article

References (86)

1. Atkas, H., H. Cai, and G. M. Cooper. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27 Kip1. Mol. Cell. Biol. 17:3850-3857.
2. Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659-669.
3. Bagchi, S., R. Weinmann, and P. Raychaudhuri. 1991. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65:1073-1082.
4. Beijersbergen, R. L., and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287:103-120.
5. Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680-2790.
6. Bruder, J. T., G. Heidecker, and U. R. Rapp. 1992. Serum-, TPA-, and Ras-induced expression from AP-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6:545-556.
7. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
8. Burgering, B. M., and J. L. Bos. 1995. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem. Sci. 20:18-22.
9. Chellappan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma. Proc. Nat. Acad. Sci. USA 89:4549-4553.
10. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein: Cell 65:1053-1061.
11. Chittenden, T., D. M. Livingston, and W. G. Kaelin, Jr. 1991. RB associates with an E2F-like, sequence-specific DNA-binding protein. Cold Spring Harbor Symp. Quant. Biol. 56:187-195.
12. Claudio, P. P., L. A. De, C. M. Howard, A. Baldi, E. J. Firpo, A. Koff, M. G. Paggi, and A. Giordano. 1996. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res. 56:2003-2008.
13. Claudio, P. P., C. M. Howard, A. Baldi, L. A. De, Y. Fu, G. Condorelli, Y. Sun, N. Colburn, B. Calabretta, and A. Giordano. 1994. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54:5556-5560.
14. Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle proteins. Curr. Top. Microbiol. Immunol. 208:32-63.
15. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392-2404.
16. Cox, L. A., G. Chen, and E. Y. Lee. 1994. Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res. Treat. 32:19-38.
17. Daum, G., I. Eisenmann-Tappe, H. W. Fries, J. Troppmair, and U. R. Rapp. 1994. The ins and outs of Raf kinases. Trends Biochem. Sci. 19:474-479.
18. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
19. DeGregori, J., G. Leone, K. Ohtani, A. Miron, and J. R. Nevins. 1995. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9:2873-2887.
20. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
21. Fabian, J. R., I. O. Daar, and D. K. Morrison. 1993. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170-7179.
22. Galaktionov, K., C. Jessus, and D. Beach. 1995. Raf-1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev. 9:1046-1058.
23. Gautier, J., M. Solomon, R. Booher, J. Bazan, and M. Kirshner. 1991. Cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67:67-72.
24. Gerwins, P., J. L. Blank, and G. L. Johnson. 1997. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 272:8288-8295.
25. Ginsberg, D., G. Vairo, T. Chittenden, Z. X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
26. Glazer, R. I., and C. Rohlff. 1994. Transcriptional regulation of multidrug resistance in breast cancer. Breast Cancer Res. Treat. 31:263-271.
27. Heidecker, G., M. Huleihel, J. L. Cleveland, W. Kolch, W. Beck, P. Lloyd, T. Pawson, and U. R. Rapp. 1990. Mutational activation of c-Raf-1 and the definition of the minimal transforming sequence. Mol. Cell. Biol. 10:2503-2512.
28. Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177-185.
29. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
30. Hollingsworth, R. J., P. L. Chen, and W. H. Lee. 1993. Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein. Curr. Opin. Cell Biol. 5:194-200.
31. Hollingsworth, R. J., C. E. Hensey, and W. H. Lee. 1993. Retinoblastoma protein and the cell cycle. Curr. Opin. Genet. Dev. 3:55-62.
32. Horowitz, J. M. 1993. Regulation of transcription by the retinoblastoma protein. Genes Chromosomes Cancer 6:124-131.
33. Jelinek, T., P. Dent, T. W. Sturgill, and M. J. Weber. 1996. Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol. Cell. Biol. 16:1027-1034.
34. Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama. 1994. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1549-1556.
35. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
36. Junaief, J. L., B. E. Strober, S. Guha, P. A. Khavari, K. Alin, J. Luban, M. Begenman, and S. P. Goff. 1994. The retinoblastoma protein and Brg1 form a complex and co-operate to induce cell cycle arrest. Cell 79:119-130.
37. Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product Cell 64:521-532.
38. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
39. Kato, J. Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713-2721.
40. Kerkhoff, E., and U. R. Rapp. 1997. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17:2576-2586.
41. La Thangue, N. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108-114.
42. Lee, C. S., A. deFazio, C. J. Ormandy, and R. L. Sutherland. 1996. Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester. J. Steroid Biochem. Mol. Biol. 58:267-275.
43. Lee, E. Y., H. To, J. Y. Shew, R. Bookstein, P. Scully, and W. H. Lee. 1988. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241:218-221.
44. Lee, W. H., R. E. Hollingsworth, Jr., Y. W. Qian, P. L. Chen, F. Hong, and E. Y. Lee. 1991. RB protein as a cellular "corral" for growth-promoting proteins. Cold Spring Harbor Symp. Quant. Biol. 56:211-217.
45. Lees, J. A., K. J. Buchkovich, D. R. Marshak, C. W. Anderson, and E. Harlow. 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:4279-4290.
46. Lehman, T. A., M. Greenblatt, W. P. Bennett, and C. C. Harris. 1994. Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Drug Metab. Rev. 26:221-235.
47. 1 checkpoint. Mol. Cell. Biol. 16:6917-6925.
48. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
49. Lumpkin, C. J., T. L. Moore, M. D. Tarpley, J. M. Taylor, T. M. Badger, and J. K. McClung. 1995. Acute ethanol and selected growth suppressor transcripts in regenerating rat liver. Alcohol 12:357-362.
50. Marais, R., Y. Light, H. F. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136-3145.
51. Mark, H. F., G. Annas, R. Ricker, and J. Weitzel. 1996. Clinical and research issues in breast cancer genetics. Ann. Clin. Lab. Sci. 26:396-408.
52. 0 lead to its association with E2F-4. Oncogene 13:237-246.
53. Mayol, S., X. Grana, A. Baldi, N. Sang, Q. Hu, and A. Giordano. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561-2566.
54. Mazzarelli, J. M., G. B. Atkins, J. V. Geisberg, and R. P. Ricciardi. 1995. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110. Oncogene 11:1859-1864.
55. McCarthy, S. A., M. L. Samuels, C. A. Pritchard, J. A. Abraham, and M. McMahon. 1995. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9:1953-1964.
56. McClung, J. K., D. B. Danner, D. A. Stewart, J. R. Smith, E. L. Schneider, C. K. Lumpkin, R. T. Dell'Orco, and M. J. Nuell. 1989. Isolation of a cDNA hybrid that selects anti-proliferative mRNA from rat liver. Biochem. Biophys. Res. Commun. 164:1316-1322.
57. McClung, J. K., R. L. King, L. S. Walker, D. B. Danner, M. J. Nuell, C. A. Stewart, and R. T. Dell'Orco. 1992. Expression of prohibitin, an amiproliferative protein. Exp. Gerontol. 27:413-417.
58. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
59. Mischak, H., T. Seitz, P. Janosch, M. Eulitz, H. Steen, M. Schellerer, A. Philipp, and W. Koldh. 1996. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16:5409-5418.
60. Morrison, D. K., D. R. Kaplan, J. A. Escobedo, U. R. Rapp, T. M. Roberts, and L. T. Williams. 1989. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell 58:649-657.
61. Muller, R., D. Mumberg, and F. C. Lucibello. 1993. Signals and genes in the control of cell cycle progression. Biochem. Biophys. Acta 1155:151-179.
62. Murray, A. W. 1992. Creative blocks: cell cycle checkpoints and feedback controls. Nature 359:599-604.
63. Murray, A. W., and T. Hunt. 1993. The cell cycle: an introduction. Oxford University Press, Oxford, United Kingdom.
64. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
65. Norbury, C., and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441-470.
66. Olah, Z., S. Komoly, N. Nagashima, F. Joo, U. R. Rappa, and W. B. Anderson. 1991. Cerebral ischemia induces transient intracellular redistribution and intranuclear translocation of the Raf proto-oncogene product in hippocampal pyramidal cells. Exp. Brain Res. 84:403-410.
67. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. DeCaprio, and M. E. Ewen. 1997. Ras signaling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177-181.
68. Pritchard, C. A., M. L. Samuels, E. Bosch, and M. McMahon. 1995. Conditionally oncogenic form of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:6430-6442.
69. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
70. Rapp, U. R. 1991. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6:495-500.
71. 1/S transition by expression of cyclins D and E with an inducible system Mol. Cell. Biol. 14:1669-1679.
72. Samuels, M. L., and M. McMahon. 1994. Inhibition of platelet-derived growth factor and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing DRaf-1:ER, an estradiol-regulated form of Raf-1. Mol. Cell. Biol. 14:7855-7866.
73. Sardet, C., M. Vidai, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-2407.
74. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
75. Sherr, C. J. 1994. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol. 4:15-18.
76. Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
77. Taya, Y. 1997. Rb kinases and RB-binding proteins: new points of view. Trends Biochem. Sci. 22:14-17.
78. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205-214.
79. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
80. Welch, P. J., and J. Y. J. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779-790.
81. Welch, P. J., and J. Y. J. Wang. 1995. Disruption of the retinoblastoma protein function by co-expression of its C pocket fragment. Genes Dev. 9:31-46.
82. Wong, K. K., X. Zou, K. T. Merrell, A. J. Patel, K. B. Marcu, S. Chellappan, and K. Calame. 1995. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15:6535-6544.
83. Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598-5611.
84. Yao, B., Y. Zhang, S. Delikat, S. Mathias, S. Basu, and R. Kolesnick. 1995. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307-310.
85. Zhu, L., S. van-den-Heuvel, K. Helin, A. Fattaey, M. Ewen, D. M. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.
86. Zou, X., S. Rudchenko, K.-K. Wong, and K. Calame. 1997. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf-1 and cyclin-dependent kinases. Genes Dev. 11:654-662.